Payment overview · 2025
General Payments
$8.30
5 reported records · 1 companies
Healthcare provider profile · identity verified
Richard L Ingram, MD
Allopathic & Osteopathic Physicians|Internal Medicine · LAGRANGE, GA · NPI 1629072699
Verified facts
What the public records show
CMS Open Payments records show Richard L Ingram, MD received $8.30 in general payments during 2025 across 5 reported records.
Travere Therapeutics, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Travere Therapeutics, Inc. | Unresolved — no canonical attribution shown | $8.30 | 100.0% | 5 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Education | $8.30 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Filspari Normalized: filspari |
Drug | Travere Therapeutics, Inc. | $8.30 | 5 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 546 | 141 |
| Atorvastatin Calcium | Atorvastatin Calcium | 491 | 145 |
| Losartan Potassium | Losartan Potassium | 476 | 117 |
| Levothyroxine Sodium | Levothyroxine Sodium | 357 | 91 |
| Hydrochlorothiazide | Hydrochlorothiazide | 270 | 68 |
| Omeprazole | Omeprazole | 224 | 59 |
| Metoprolol Tartrate | Metoprolol Tartrate | 221 | 57 |
| Gabapentin | Gabapentin | 218 | 56 |
| Metformin Hcl | Metformin Hcl | 214 | 61 |
| Potassium Chloride | Potassium Chloride | 209 | 59 |
| Metoprolol Succinate | Metoprolol Succinate | 205 | 56 |
| Spironolactone | Spironolactone | 189 | 55 |
| Allopurinol | Allopurinol | 180 | 43 |
| Lisinopril | Lisinopril | 176 | 47 |
| Tamsulosin Hcl | Tamsulosin Hcl | 159 | 37 |
| Pantoprazole Sodium | Pantoprazole Sodium | 137 | 47 |
| Furosemide | Furosemide | 133 | 41 |
| Torsemide | Torsemide | 131 | 46 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 125 | 36 |
| Famotidine | Famotidine | 124 | 39 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 124 | 25 |
| Ezetimibe | Ezetimibe | 123 | 32 |
| Nifedipine Er | Nifedipine | 119 | 37 |
| Prednisone | Prednisone | 113 | 34 |
| Glipizide Er | Glipizide | 108 | 29 |
| Pravastatin Sodium | Pravastatin Sodium | 108 | 25 |
| Simvastatin | Simvastatin | 99 | 28 |
| Eliquis | Apixaban | 98 | 25 |
| Atenolol | Atenolol | 91 | 25 |
| Chlorthalidone | Chlorthalidone | 89 | 24 |
| Fluticasone Propionate | Fluticasone Propionate | 86 | 41 |
| Enalapril Maleate | Enalapril Maleate | 85 | 22 |
| Amiloride Hcl | Amiloride Hcl | 83 | 20 |
| Citalopram Hbr | Citalopram Hydrobromide | 82 | 17 |
| Clopidogrel | Clopidogrel Bisulfate | 82 | 20 |
| Alprazolam | Alprazolam | 81 | 31 |
| Carvedilol | Carvedilol | 76 | 26 |
| Montelukast Sodium | Montelukast Sodium | 73 | 23 |
| Sertraline Hcl | Sertraline Hcl | 69 | 23 |
| Buspirone Hcl | Buspirone Hcl | 68 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 62 | 41 |
| Finasteride | Finasteride | 61 | 15 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 59 | 59 |
| Escitalopram Oxalate | Escitalopram Oxalate | 54 | 13 |
| Azithromycin | Azithromycin | 51 | 42 |
| Fluoxetine Hcl | Fluoxetine Hcl | 51 | 17 |
| Clonidine Hcl | Clonidine Hcl | 50 | 15 |
| Trulicity | Dulaglutide | 49 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 44 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 44 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 44 | 13 |
| Sevelamer Carbonate | Sevelamer Carbonate | 44 | 12 |
| Tresiba Flextouch U-100 | Insulin Degludec | 38 | suppressed |
| Glipizide | Glipizide | 37 | 14 |
| Fenofibrate | Fenofibrate Nanocrystallized | 36 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 35 | suppressed |
| Rybelsus | Semaglutide | 34 | suppressed |
| Amoxicillin | Amoxicillin | 31 | 28 |
| Trazodone Hcl | Trazodone Hcl | 31 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 31 | suppressed |
| Eplerenone | Eplerenone | 29 | suppressed |
| Januvia | Sitagliptin Phosphate | 29 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 29 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 28 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 27 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 27 | 20 |
| Doxazosin Mesylate | Doxazosin Mesylate | 26 | suppressed |
| Tradjenta | Linagliptin | 26 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 25 | suppressed |
| Methotrexate | Methotrexate Sodium | 25 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 25 | suppressed |
| Synthroid | Levothyroxine Sodium | 25 | suppressed |
| Clotrimazole | Clotrimazole | 24 | 11 |
| Humalog Kwikpen U-100 | Insulin Lispro | 24 | suppressed |
| Indapamide | Indapamide | 22 | suppressed |
| Ozempic | Semaglutide | 22 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 22 | 12 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 22 | suppressed |
| Kerendia | Finerenone | 21 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 21 | 18 |
| Donepezil Hcl | Donepezil Hcl | 20 | suppressed |
| Felodipine Er | Felodipine | 20 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 20 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 20 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 19 | suppressed |
| Verapamil Sr | Verapamil Hcl | 19 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 18 | 11 |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 18 | suppressed |
| Cephalexin | Cephalexin | 18 | 15 |
| Glimepiride | Glimepiride | 18 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 18 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 18 | suppressed |
| Auryxia | Ferric Citrate | 17 | suppressed |
| Clonazepam | Clonazepam | 17 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 17 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 17 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 17 | suppressed |
| Valsartan | Valsartan | 17 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 16 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 16 | 15 |
| Propranolol Hcl | Propranolol Hcl | 16 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Veltassa | Patiromer Calcium Sorbitex | 16 | suppressed |
| Verapamil Er | Verapamil Hcl | 16 | suppressed |
| Bupropion Xl | Bupropion Hcl | 15 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 15 | suppressed |
| Mupirocin | Mupirocin | 15 | suppressed |
| Pentips Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 15 | suppressed |
| Febuxostat | Febuxostat | 14 | suppressed |
| Levemir | Insulin Detemir | 14 | suppressed |
| Levemir Flexpen | Insulin Detemir | 14 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 14 | suppressed |
| Methimazole | Methimazole | 14 | suppressed |
| Metolazone | Metolazone | 14 | suppressed |
| Novolog Flexpen | Insulin Aspart | 14 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 14 | suppressed |
| Baclofen | Baclofen | 13 | suppressed |
| Jardiance | Empagliflozin | 13 | suppressed |
| Klor-Con 10 | Potassium Chloride | 13 | suppressed |
| Lansoprazole | Lansoprazole | 13 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 12 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 12 | suppressed |
| Meloxicam | Meloxicam | 12 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 12 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 12 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 11 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 11 | suppressed |
| Hydrocortisone | Hydrocortisone | 11 | suppressed |
| Insulin Lispro | Insulin Lispro | 11 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 11 | suppressed |
| Mounjaro | Tirzepatide | 11 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $8.30 · 5 records | Travere Therapeutics, Inc. | Filspari | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error